Provided by Tiger Trade Technology Pte. Ltd.

Sonoma Pharmaceuticals, Inc.

2.91
-0.1200-3.96%
Post-market: 2.910.00000.00%16:10 EST
Volume:27.62K
Turnover:82.01K
Market Cap:4.95M
PE:-1.33
High:3.10
Open:3.03
Low:2.87
Close:3.03
52wk High:6.92
52wk Low:1.75
Shares:1.70M
Float Shares:1.62M
Volume Ratio:1.60
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1867
EPS(LYR):-2.7857
ROE:-76.14%
ROA:-14.16%
PB:1.31
PE(LYR):-1.04

Loading ...

Sonoma Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Vanessa Jacoby

Reuters
·
2 hours ago

Sonoma Pharmaceuticals Appoints Vanessa Jacoby to Board as Jay Birnbaum Retires

Reuters
·
Jan 29

Sonoma Pharmaceuticals Grants Equity Awards to Executives and Directors

Reuters
·
Jan 03

Sonoma Pharmaceuticals to Exhibit at MEDICA in Düsseldorf

Reuters
·
Nov 07, 2025

Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales

Reuters
·
Nov 04, 2025

BRIEF-Sonoma Pharmaceuticals Q2 Net Income USD -500 Thousand

Reuters
·
Nov 04, 2025

Sonoma Pharmaceuticals Q2 Gross Profit USD 2.1 Million

THOMSON REUTERS
·
Nov 04, 2025

Sonoma Pharmaceuticals Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Sonoma Pharmaceuticals Inc - on Oct 18, Bruce Thornton Terminated as Executive Vice President and COO - SEC Filing

THOMSON REUTERS
·
Oct 24, 2025

Sonoma Pharmaceuticals Fires COO Bruce Thornton for Cause

Reuters
·
Oct 24, 2025

Sonoma Pharmaceuticals announces new compensation agreement for CEO Amy Trombly

Reuters
·
Oct 10, 2025

Sonoma Pharmaceuticals Secures FDA MoCRA Registration for Microcyn-Based Cosmetic Products, Expanding U.S. Market Access

Reuters
·
Oct 07, 2025

Sonoma Pharmaceuticals Inc - Enters at Market Issuance Sales Agreement With Ladenburg - SEC Filing

THOMSON REUTERS
·
Sep 27, 2025

Sonoma Pharmaceuticals Announces At-The-Market Offering of Common Stock Worth Up to $2.07 Million

Reuters
·
Sep 27, 2025

Sonoma Pharmaceuticals Inc. to Participate in Lytham Partners Fall 2025 Investor Conference

Reuters
·
Sep 26, 2025

Sonoma Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
Aug 30, 2025